Stock listing
NASDAQ:ALKS Alkermes plc Stock
Home listing (NASDAQ) of Alkermes plc
Follow Alkermes plc into a list and get an email when it puts out news.
Share price · NASDAQ:ALKS
$45.34 USD -0.03 (-0.1%)
Close on Oct 30, 2026
- Day range
- $44.78 – $46.35 USDOct 30, 2026
- Volume
- 1.10M sharesOct 30, 2026
- Market cap
- $7.61B USDAt the close on Oct 30, 2026 · price × 167.8M shares outstanding
- 52-week range
- $27.00 – $55.67 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $81.87M USDMedian day 1.56M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALKS · Home | $45.34 USD | -0.03 (-0.1%) | 1,103,100 | $46.05 | $46.35 | $44.78 | $45.37 | Close on Oct 30, 2026 |
| Frankfurt:8AK | €39.63 EUR | +0.22 (+0.6%) | — | €39.49 | €39.63 | €39.49 | €39.41 | Close on Oct 27, 2026 |
| Munich:8AK | €39.90 EUR | +0.61 (+1.6%) | — | €39.90 | €39.90 | €39.90 | €39.29 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ALKS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $45.34 | -0.03 | -0.1% | $46.05 | $46.35 | $44.78 | 1,103,100 | |
| $45.37 | +0.12 | +0.3% | $46.01 | $46.38 | $45.18 | 1,424,102 | |
| $45.25 | +0.93 | +2.1% | $43.66 | $45.29 | $43.45 | 1,439,609 | |
| $44.32 | -0.12 | -0.3% | $44.34 | $45.02 | $43.99 | 1,322,006 | |
| $44.44 | +0.81 | +1.9% | $44.11 | $44.84 | $43.60 | 1,176,591 | |
| $43.63 | -0.55 | -1.2% | $44.15 | $44.15 | $43.15 | 884,392 | |
| $44.18 | +0.70 | +1.6% | $44.00 | $44.68 | $43.46 | 1,833,975 | |
| $43.48 | -0.63 | -1.4% | $44.12 | $44.58 | $43.44 | 1,781,814 | |
| $44.11 | +1.14 | +2.7% | $43.38 | $45.19 | $43.21 | 2,154,017 | |
| $42.97 | +1.75 | +4.2% | $41.46 | $43.64 | $41.35 | 2,713,432 | |
| $41.22 | +1.12 | +2.8% | $40.18 | $41.57 | $39.71 | 3,408,302 | |
| $40.10 | +1.02 | +2.6% | $39.74 | $40.74 | $39.42 | 1,976,642 | |
| $39.08 | -0.65 | -1.6% | $39.59 | $40.65 | $38.98 | 1,551,180 | |
| $39.73 | -0.53 | -1.3% | $40.26 | $40.35 | $39.67 | 1,068,300 | |
| $40.26 | -0.35 | -0.9% | $40.67 | $40.87 | $40.00 | 2,240,200 | |
| $40.61 | +0.50 | +1.2% | $40.18 | $40.87 | $39.99 | 1,627,000 | |
| $40.11 | -1.34 | -3.2% | $41.10 | $41.26 | $39.11 | 3,251,000 | |
| $41.45 | -0.20 | -0.5% | $41.28 | $42.06 | $41.17 | 1,816,000 | |
| $41.65 | -1.11 | -2.6% | $42.64 | $42.71 | $41.24 | 1,546,000 | |
| $42.76 | +1.01 | +2.4% | $42.07 | $43.22 | $41.67 | 3,125,200 | |
| $41.75 | +1.21 | +3.0% | $41.03 | $41.96 | $40.32 | 2,423,500 | |
| $40.54 | +0.02 | 0.0% | $40.00 | $41.41 | $39.99 | 2,625,700 | |
| $40.52 | -0.28 | -0.7% | $40.94 | $40.94 | $39.92 | 2,527,200 | |
| $40.80 | +0.65 | +1.6% | $39.84 | $40.90 | $39.84 | 2,686,800 | |
| $40.15 | -0.70 | -1.7% | $40.71 | $40.97 | $40.04 | 2,356,200 | |
| $40.85 | +0.06 | +0.1% | $40.94 | $41.12 | $40.49 | 2,588,000 | |
| $40.79 | -1.34 | -3.2% | $42.55 | $42.55 | $40.59 | 2,843,400 | |
| $42.13 | -1.16 | -2.7% | $43.20 | $43.62 | $41.23 | 2,475,700 | |
| $43.29 | -0.89 | -2.0% | $44.39 | $44.53 | $43.08 | 2,310,700 | |
| $44.18 | +0.79 | +1.8% | $44.27 | $44.79 | $43.11 | 3,731,100 | |
| $43.39 | -3.32 | -7.1% | $46.51 | $46.53 | $43.27 | 6,935,802 | |
| $46.71 | +0.64 | +1.4% | $47.10 | $47.40 | $46.41 | 1,423,600 | |
| $46.07 | +0.04 | +0.1% | $46.64 | $47.26 | $45.79 | 1,854,600 | |
| $46.03 | +0.20 | +0.4% | $45.73 | $46.14 | $44.63 | 2,151,200 | |
| $45.83 | -0.14 | -0.3% | $46.60 | $46.60 | $45.66 | 2,029,500 | |
| $45.97 | -0.14 | -0.3% | $46.75 | $46.75 | $45.73 | 1,283,100 | |
| $46.11 | +0.71 | +1.6% | $44.98 | $46.11 | $44.75 | 1,193,900 | |
| $45.40 | -0.09 | -0.2% | $45.24 | $45.61 | $44.72 | 1,442,800 | |
| $45.49 | -0.61 | -1.3% | $45.20 | $46.53 | $44.63 | 1,355,800 | |
| $46.10 | -0.78 | -1.7% | $46.14 | $46.93 | $45.80 | 1,064,000 | |
| $46.88 | -0.84 | -1.8% | $48.01 | $48.29 | $46.71 | 974,500 | |
| $47.72 | +0.52 | +1.1% | $47.70 | $48.74 | $46.68 | 1,566,400 | |
| $47.20 | +0.21 | +0.4% | $47.00 | $47.34 | $46.65 | 1,351,300 | |
| $46.99 | -0.42 | -0.9% | $47.25 | $47.56 | $46.46 | 1,440,900 | |
| $47.41 | -1.49 | -3.0% | $48.82 | $48.82 | $47.25 | 1,429,200 | |
| $48.90 | -0.26 | -0.5% | $48.72 | $49.33 | $48.10 | 2,119,400 | |
| $49.16 | -0.05 | -0.1% | $49.23 | $49.35 | $48.46 | 660,900 | |
| $49.21 | +0.34 | +0.7% | $48.94 | $49.58 | $48.87 | 1,127,442 | |
| $48.87 | +0.54 | +1.1% | $48.05 | $49.03 | $47.64 | 1,296,669 | |
| $48.33 | +0.31 | +0.6% | $48.05 | $48.67 | $47.33 | 939,600 | |
| $48.02 | -2.16 | -4.3% | $49.37 | $49.86 | $47.93 | 1,635,200 | |
| $50.18 | +0.70 | +1.4% | $51.26 | $51.29 | $50.08 | 1,544,200 | |
| $49.48 | -0.37 | -0.7% | $50.10 | $50.42 | $49.46 | 970,900 | |
| $49.85 | +0.79 | +1.6% | $48.90 | $50.08 | $48.62 | 763,800 | |
| $49.06 | -0.39 | -0.8% | $49.37 | $50.02 | $48.65 | 1,267,800 | |
| $49.45 | -0.83 | -1.7% | $51.66 | $51.66 | $49.21 | 1,546,600 | |
| $50.28 | +1.07 | +2.2% | $49.22 | $50.53 | $48.50 | 1,315,600 | |
| $49.21 | -0.19 | -0.4% | $49.92 | $50.14 | $48.97 | 1,373,600 | |
| $49.40 | +0.23 | +0.5% | $48.39 | $49.81 | $48.39 | 1,511,300 | |
| $49.17 | +0.80 | +1.7% | $49.05 | $49.90 | $48.67 | 1,111,000 | |
| $48.37 | -1.24 | -2.5% | $49.61 | $50.40 | $48.21 | 1,569,100 | |
| $49.61 | -0.06 | -0.1% | $50.20 | $50.85 | $49.23 | 1,706,800 | |
| $49.67 | +0.14 | +0.3% | $49.73 | $50.36 | $49.00 | 1,430,800 | |
| $49.53 | +0.54 | +1.1% | $48.58 | $50.71 | $48.19 | 1,835,700 | |
| $48.99 | -1.04 | -2.1% | $49.63 | $49.83 | $48.52 | 1,624,500 | |
| $50.03 | +1.69 | +3.5% | $47.85 | $50.34 | $47.71 | 2,303,300 |
- Ticker
- NASDAQ:ALKS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Alkermes Expands ALKS 7290 Development Program With Initiation of Phase 2 Study for the Adjunctive Treatment of Major Depressive Disorder (MDD)
Latest earnings call · Jul 28, 2026
Alkermes (NASDAQ:ALKS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 28, 2026
Q2 2026 Earnings Presentation
Earnings · 16 slides
Calls
Upcoming
Alkermes (NASDAQ:ALKS) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Register
Replays
Alkermes (NASDAQ:ALKS) Q2 2026 Earnings Call
Tue, Jul 28, 2026 · 8:00 AM ET
Watch TranscriptAlkermes (NASDAQ:ALKS) Q1 2026 Earnings Call
Tue, May 05, 2026 · 8:00 AM ET
Watch TranscriptAlkermes (NASDAQ:ALKS) Q4 2026 Earnings Call
Wed, Feb 25, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Alkermes Expands ALKS 7290 Development Program With Initiation of Phase 2 Study for the Adjunctive Treatment of Major Depressive Disorder (MDD)
Oct 30, 2026
Closed $45.34 (-0.1%) on Oct 30, 2026
Alkermes to Report Third Quarter Financial Results on November 3, 2026
Oct 20, 2026
Closed $43.48 (-1.4%) on Oct 21, 2026
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
Oct 13, 2026
Closed $39.73 (-1.3%) on Oct 13, 2026
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Sep 21, 2026
Closed $44.18 (+1.8%) on Sep 21, 2026
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
Sep 16, 2026
Closed $46.07 (+0.1%) on Sep 16, 2026
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
Sep 10, 2026
Closed $46.11 (+1.6%) on Sep 10, 2026
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
Aug 24, 2026
Closed $49.21 (+0.7%) on Aug 25, 2026
Alkermes plc Reports Second Quarter 2026 Financial Results
Jul 28, 2026
Closed $50.50 (-4.2%) on Jul 28, 2026
Alkermes to Report Second Quarter Financial Results on July 28, 2026
Jul 14, 2026
Closed $51.98 (+0.7%) on Jul 15, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 16 slides · Jul 28, 2026
SLEEP 2026
Conference · 19 slides · Jun 17, 2026
Q1 2026 Earnings Presentation
Earnings · 16 slides · May 5, 2026
Q4 2026 Earnings Presentation
Earnings · 19 slides · Feb 25, 2026
Alkermes plc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 38 in the last 12 months · 248 in all · newest Oct 30, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Jul 28, 2026
- Decks
- 72 decks · latest Jul 28, 2026
Where Alkermes plc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALKS · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A1JKVH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1JKVH | Lang & Schwarz | Germany | EUR |
| BOATS:ALKS | BOATS | United States | USD |
| Frankfurt:8AK | Frankfurt | Germany | EUR |
| Tradegate:8AK | Tradegate | Germany | EUR |
| Munich:8AK | Munich | Germany | EUR |
| Stuttgart:8AK | Stuttgart | Germany | EUR |
| Xetra:8AK | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Alkermes plc.